Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...

US biotech Cartesian Therapeutics has reported that patients with generalized myasthenia gravis (gMG) continued to experience ...

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...

Johnson & Johnson (NYSE:JNJ) announced compelling results from its Phase 3 Vivacity-MG3 study on nipocalimab, showing ...

On (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of ...

On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and ...

Neogen Corporation reports lower-than-expected Q3 earnings, declines in revenue, and a CEO transition, lowering its full-year ...

US-based biotech Rallybio is ending its RLYB212 programme for the prevention of fetal and neonatal alloimmune ...

It was a busy week for the biotech sector, with lots of regulatory and pipeline updates amid fears of a global recession ...

Luxury beauty brand SWISS REJU is Hong Kong's No.1 Best Body Slimming and Contouring Provider, according to Sunday More ...

My fiance and I plan to have kids someday. I was wondering if it would be beneficial to keep our babies’ umbilical cords, which would be full of ...

U.S. stock futures were volatile on Wednesday after the equities reversed gains on Tuesday following Donald Trump's 104% tariff on China.